CNS SEDATIVES

Chapter 21: Introduction to the Pharmacology of CNS Drugs

1. Introduction to CNS Drugs

  • CNS drugs were among the first pharmacologic agents discovered by humans.

  • Widely used for treating neurologic and psychiatric conditions; also provide symptom relief (pain, nausea, fever).

  • Many CNS drugs are used recreationally for enhancing well-being.

  • Advances in CNS pharmacology allow study at neuron and receptor levels, improving understanding of their effects.

2. Mechanisms of CNS Drug Action

  • Agonists and Antagonists: Most CNS-active drugs work on specific receptors to modulate synaptic transmission.

    • Exceptions: General anesthetics and alcohol may have non-specific membrane actions.

  • Research Implications: Understanding drug actions aids in developing hypotheses about CNS diseases.

  • Notable Studies: Effects of drugs on dopamine and GABA receptors have helped form hypotheses for schizophrenia, anxiety, and epilepsy.

3. Organization of the CNS

  • CNS Components: Includes the brain and spinal cord, with around 100 billion interconnected neurons supported by glial cells.

  • Neurons: Classified by location, function, and neurotransmitter type.

    • Components: Cell body (soma), dendrites (receive inputs), and axon (transmit outputs).

    • Synapses: Junctions where neurotransmitters are released to communicate with other neurons.

3.1 Types of Neurons

  • Neurons are grouped into nuclei or arranged in layers (e.g., cerebellum, hippocampus).

    • Dendritic Trees: Highly branched, allowing integration of synaptic inputs.

    • Axon Action: Conducts output signals and forms synapses.

4. Neuroglia and Their Functions

  • Astrocytes: Provide support, metabolic nutrients, and regulate extracellular ion concentrations.

    • Involved in neurotransmitter recycling.

  • Oligodendrocytes: Form myelin sheath around axons, essential for rapid signal conduction.

  • Microglia: Act as the brain's immune cells, involved in inflammation and synaptic pruning.

5. Blood-Brain Barrier (BBB)

  • Function: Protects CNS by limiting substance entry through tight junctions between endothelial cells.

  • Drug Penetration: Requires lipophilicity or specific transport mechanisms.

    • Example: L-DOPA crossing BBB but dopamine does not.

6. Ion Channels and Neurotransmitter Receptors

  • Channel Types: Voltage-gated (response to membrane potential) and ligand-gated (response to neurotransmitter binding).

    • Toxin Studies: Various natural toxins help characterize ion channels.

  • Receptor Interaction: Metabotropic receptors interact with G proteins, influencing second messenger systems.

7. Synaptic Transmission

  • Process Overview: Synaptic communication involves neurotransmitter release and interaction with postsynaptic receptors.

    • Action potentials cause calcium channels to open, leading to neurotransmitter release into synapses.

    • Responses include regulatory excitatory postsynaptic potentials (EPSPs) and inhibitory postsynaptic potentials (IPSPs).

8. Sites of Drug Action

  • Drugs can modify synaptic transmission at presynaptic and postsynaptic levels.

    • Presynaptic Modifications: Involves neurotransmitter synthesis, release, and uptake.

    • Postsynaptic Modifications: Involves receptor agonism or antagonism.

9. Cellular Organization of the Brain

  • Hierarchical Systems: Involve pathways for sensory perception and motor control with clear neuron pathways.

  • Diffuse Systems: Utilize monoamines and affect widespread regions for global functions (e.g., attention, arousal).

10. Central Neurotransmitters

  • Key Neurotransmitters: Defined by localization, receptor type, and pharmacologic action.

    • Major neurotransmitters include acetylcholine, dopamine, GABA, serotonin, and norepinephrine.

11. Pharmacological Profile of Drugs

  • Benzodiazepines and Barbiturates: Affect the GABA receptor for sedation and anxiolytic effects.

  • Selective Use: New hypnotics and melatonin receptor agonists emerge as options for sleep disorders (e.g., ramelteon).

12. Clinical Applications and Toxicology

  • Therapeutic Use: CNS drugs are used for anxiety, insomnia, and seizures but carry the risk of dependence and withdrawal.

  • Toxicity: Overdose and CNS depression are critical concerns, necessitating cautious prescribing.